General MedicationsINJECTIONStandard

VINBLASTINE SULFATE

Standard Dose

1MG/ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: UNKNOWN Marketing status: Prescription

Summary

Approval overview VINBLASTINE SULFATE is listed in Drugs@FDA under application 089515 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient VINBLASTINE SULFATE Form and strength INJECTABLE;INJECTION - 1MG/ML Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2021-10-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview VINBLASTINE SULFATE is listed in Drugs@FDA under application 089515 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient VINBLASTINE SULFATE Form and strength INJECTABLE;INJECTION - 1MG/ML Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2021-10-25 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: UNKNOWN

Interaction Notes

No interaction notes stored yet.